Risk factors for perianeurysmal vasogenic oedema (pavo) following embolization therapy: literature review

Mensah, Emmanuel O.; Abusellie, Abdul R.; Pringle, Catherine; Emsley, Hedley; Alalade, Andrew F.; Roberts, Gareth A.

doi:10.1007/s10143-023-02168-0

Neurosurg Rev

2023

DOI: 10.1007/s10143-023-02168-0

|View full text |Cite

Risk factors for perianeurysmal vasogenic oedema (pavo) following embolization therapy: literature review

Emmanuel O. Mensah,

Abdul R. Abusellie,

Catherine Pringle

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 43 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Perianeurysmal vasogenic oedema (PAVO): A single centre 10-year retrospective review

Verma,

Pringle,

Emsley

et al. 2024

Neuroradiol J

View full text Add to dashboard Cite

Introduction Perianeurysmal Vasogenic Oedema (PAVO) is a rare but important complication of endovascular treatment of intracranial aneurysms. Many potential risk factors have been identified including age, aneurysm size, aneurysm location, immunological profile, type of coil used, diabetes, hypertension, and smoking. PAVO can cause persistent post-procedural symptoms, subsequently increasing post-embolization morbidity. Methods A 10-year retrospective review was conducted between 2011 and 2021 at Royal Preston Hospital, Preston, UK. Results We identified 8 patients that fit our inclusion criteria. This included 6 (75%) females and 2 (25%) males. The mean age was 64. All patients had anterior circulation aneurysms with the middle cerebral artery (MCA) being the most common site. The mean aneurysm size was 12 mm. Our patients were managed with a range of endovascular techniques. One patient had pre-treatment PAVO while 7 patients had post-embolization PAVO. Five patients were symptomatic, and 3 cases were asymptomatic with only radiological evidence of PAVO. Five patients were managed with varying courses of dexamethasone. PAVO resolution was achieved in 4 cases. The oedema significantly improved in 3 cases, but transiently progressed in 1 case. Conclusions PAVO is a rare but important complication of endovascular management of intracranial aneurysms. We have shown that patients can be effectively managed with steroids with resultant oedema regression and symptomatic improvement. Many risk factors have been associated with PAVO, but further research is needed to better understand their role in PAVO development and help develop other therapeutic options.

show abstract

Perianeurysmal vasogenic oedema (PAVO): A single centre 10-year retrospective review

Verma,

Pringle,

Emsley

et al. 2024

Neuroradiol J

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Risk factors for perianeurysmal vasogenic oedema (pavo) following embolization therapy: literature review

Cited by 1 publication

References 43 publications

Perianeurysmal vasogenic oedema (PAVO): A single centre 10-year retrospective review

Perianeurysmal vasogenic oedema (PAVO): A single centre 10-year retrospective review

Contact Info

Product

Resources

About